{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_017654.3:c.5095T>C",
          "cDNA Change": {
            "transcript": "NM_017654.3",
            "ref": "T",
            "alt": "C",
            "position": "5095"
          },
          "Protein Change": {
            "ref": "Y",
            "alt": "C",
            "position": "1699"
          },
          "Description in input context": "Y1699C mutation in the LRRK2 gene, associated with reduced GTPase activity and altered dimerization"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005294"
  },
  "Experiment Method": [
    {
      "Assay Method": "GTPase Activity Assay",
      "Material used": {
        "Material Source": "Recombinant protein",
        "Material Name": "LRRK2 variants (Y1699C, R1441C, wild-type)",
        "Description": "Assays were performed using recombinant LRRK2 variants and wild-type controls."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_017654.3:c.5095T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced GTPase activity",
          "Result Description": "Y1699C showed a 60% reduction in GTPase activity compared to wild-type, similar to R1441C."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "GTPase activity ≥ 80% of wild-type",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "GTPase activity < 50% of wild-type",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Dimerization Study (Co-IP/Fluorescence Resonance Energy Transfer)",
      "Material used": {
        "Material Source": "Cell culture",
        "Material Name": "HEK293 cells overexpressing LRRK2 variants",
        "Description": "Dimerization was assessed using immunoprecipitation and FRET techniques."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_017654.3:c.5095T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Altered dimerization",
          "Result Description": "Y1699C showed reduced dimerization compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Dimerization ≥ 80% of wild-type",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Dimerization < 50% of wild-type",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Competition Assay (Binding Affinity Test)",
      "Material used": {
        "Material Source": "In vitro binding",
        "Material Name": "LRRK2 ROC and COR domains",
        "Description": "Competition assays were performed to assess binding affinity between ROC and COR domains."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_017654.3:c.5095T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced binding affinity",
          "Result Description": "Y1699C showed reduced binding affinity between ROC and COR domains."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type ROC and COR domains were used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Non-specific peptides were used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Binding affinity ≥ 80% of wild-type",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Binding affinity < 50% of wild-type",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "3D Homology Modeling",
      "Material used": {
        "Material Source": "Computational",
        "Material Name": "LRRK2 structure data",
        "Description": "Homology modeling was performed to predict the structural impact of Y1699C."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_017654.3:c.5095T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Structural destabilization",
          "Result Description": "Modeling suggested Y1699C disrupts the active site conformation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not applicable for computational methods."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not applicable for computational methods."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not applicable for computational methods."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not applicable for computational methods."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D.",
        "Source": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D.",
        "Source": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}